Congress remains out of town this week.  Here are a couple of mop-up items from the Hill newspaper:

• CMS unveiled its new 2017 value based comprehensive primary care program for Medicare in 16 states. The American Medical Association was pleased with the program “at first glance.”   Improving primary care in Medicare helps the FEHBP because so many FEHBP enrollees have primary Medicare coverage.  
• The Centers for Disease Control issued a study on tobacco smoking use in the U.S.  The report finds tha use remains high among certain ethic groups. The study suggests focusing anti-smoking efforts on those groups. 

Bloomberg reports that “U.S. District Judge John Bates in Washington {DC] said Friday he would keep the case against Aetna Inc.’s deal for Humana Inc., leaving the challenge to Anthem Inc.’s takeover of Cigna Corp. to another judge. Bates kept the Aetna case because it’s on a tighter deadline with its merger agreement expiring at the end of the year.” The article adds that “The Anthem case was assigned to Judge Amy Berman Jackson in Washington, who was appointed to the bench by President Barack Obama.”

Judge Berman promptly issued the following scheduling orderin the Anthem / Cigna merger case:

In light of the August 5, 2016 reassignment of United States v. Anthem, Inc. to this Court 41 , the Court has reviewed the status reports submitted by the parties 28 , 29 , and 30 , the transcript of the status conference held in this case and in United States v. Aetna, 16-1494 on August 4, 2016 39 , as well as the Order issued in both cases on August 5, 2016 40 . Since this Court agrees that it is advisable to appoint a single Special Master to facilitate efficient discovery in both of these cases, the parties to the Anthem case are directed to submit any recommendations concerning that appointment to this Court, as well as to the court in United States v. Aetna, by filing them on the docket in both cases by 5:00 pm on August 8, 2016. A scheduling conference will be held in Courtroom 3 on Friday, August 12 at 10:00 am. The parties are further ordered to meet and confer and submit a joint report pursuant to L.Cv.R. 16.3 by 5:00 pm on Wednesday, August 10. The report should include a proposed discovery schedule as well as each side’s current best estimate as to the amount of time needed to present its case assuming that some portion of the evidence may be submitted in the form of written testimony well in advance of trial, and it should address counsels’ availability — and identify any dates on which they are not available — in December 2016 and January 2017. 

Bloomberg reports that “U.S. District Judge John Bates in Washington {DC] said Friday he would keep the case against Aetna Inc.’s deal for Humana Inc., leaving the challenge to Anthem Inc.’s takeover of Cigna Corp. to another judge. Bates kept the Aetna case because it’s on a tighter deadline with its merger agreement expiring at the end of the year.” The article adds that “The Anthem case was assigned to Judge Amy Berman Jackson in Washington, who was appointed to the bench by President Barack Obama.”

Judge Berman promptly issued the following scheduling orderin the Anthem / Cigna merger case:

In light of the August 5, 2016 reassignment of United States v. Anthem, Inc. to this Court 41 , the Court has reviewed the status reports submitted by the parties 28 , 29 , and 30 , the transcript of the status conference held in this case and in United States v. Aetna, 16-1494 on August 4, 2016 39 , as well as the Order issued in both cases on August 5, 2016 40 . Since this Court agrees that it is advisable to appoint a single Special Master to facilitate efficient discovery in both of these cases, the parties to the Anthem case are directed to submit any recommendations concerning that appointment to this Court, as well as to the court in United States v. Aetna, by filing them on the docket in both cases by 5:00 pm on August 8, 2016. A scheduling conference will be held in Courtroom 3 on Friday, August 12 at 10:00 am. The parties are further ordered to meet and confer and submit a joint report pursuant to L.Cv.R. 16.3 by 5:00 pm on Wednesday, August 10. The report should include a proposed discovery schedule as well as each side’s current best estimate as to the amount of time needed to present its case assuming that some portion of the evidence may be submitted in the form of written testimony well in advance of trial, and it should address counsels’ availability — and identify any dates on which they are not available — in December 2016 and January 2017. 

 Aetna and Humana urged [Federal District Judge John] Bates this week to hold trials and issue an opinion by the end of 2016. Bates said in a pre-trial hearing on Thursday that was unlikely to happen.

“That’s my determination: that I can’t do both (by the end of the year),” he said. “Unless the schedule is put off, I’m sending one of the cases back.” Bates declined to say which would be sent for reassignment.

Christopher Curran, a lawyer representing Anthem, said at the hearing that the failure to get a favorable ruling by year-end would doom the deal because Cigna would not agree to an extension.

“We’re in this pickle through no fault of our own,” he said, noting that the Justice Department had taken a year to decide whether it would file a complaint to stop the merger.

John Majoras, the lawyer representing Aetna, pushed at the hearing for a fall trial. He argued that his client’s deal had been announced first and was simpler.

Interesting.

Here are several end of the week tidbits:

• OCR took another scalp yesterday.  Healthcare IT News reports that “After multiple potential HIPAA violations involving electronic protected health information, Illinois-based Advocate Health Care Network has settled with the U.S. Department of Health and Human Services’ Office of Civil Rights for $5.55 million.” That’s OCR’s largest single recovery. 
• Tammy Flanagan reports on a recent research study of federal employees principally on retirement issues.
• Prof. Timothy Jost informs us about a newly proposed IRS rule concerning the complicated IRC 6055 / Form 1095B report process that health plans, including FEHB plans, must follow. 
• Kaiser Health News give us the latest on HHS’s program to penalize hospitals for purportedly unnecessary readmissions:

The federal government’s readmission penalties on hospitals will reach a new high as Medicare withholds more than half a billion dollars in payments over the next year, records released Tuesday show.  The government will punish more than half of the nation’s hospitals — a total of 2,597 — having more patients than expected return within a month. While that is about the same number penalized last year, the average penalty will increase by a fifth, according to a Kaiser Health News analysis.

Yesterday, CMS finalized its Medicare Part A prospective payment system rule for inpatient hospital services, and Modern Healthcare’s lede suggests that it’s not good news for hospitals.

In a final rule released Tuesday, the CMS said it will keep a controversial 1.5% cut to hospital reimbursement. Industry stakeholders had rallied against the move which aims to recoup a total of $11 billion in overpayments.  Hospitals expected the cut to remain at 0.8%​—as it has been ever year since 2014, two years after Congress mandated the CMS to recover funds allegedly lost as a result of incorrect coding on inpatient hospital stays.

The rule takes effect on October 1, 2016.  Robert Moffitt from the Heritage Foundation offer his expert views on the next 50 years of the Medicare Program here.  The FEHBlog predicts more Medicare cost shifting to FEHBP and other employer sponsored and for that matter ACA marketplace plans in the near term.

The Drug Channels blog offers seven takeaways from his review of the initial (subject to change) 2017 formulary lists released by CVS Caremark and Express Scripts. It’s interesting to see how the two companies’ strategies stack up.

Now that the political party conventions are over, members of Congress have five weeks to concentrate on the campaign trail, fund raising, etc. FYI, the Summer Olympics caused the back to back scheduling of the political party conventions and the late July scheduling of the PGA Championship.

The New York Times this morning offers a fascinating and lengthy article about the use of immunotherapy to treat certain cancers, including lung cancer.  Immunotherapy uses drugs to block so-called checkpoints that limit the strength of the human body’s killer cells known as T cells.  As the article explains,  this is the treatment that President Carter received to cure his advanced melanoma. Immunotherapy is not a sure thing but it is another tool to use along with radiation and chemotherapy.

Speaking of drugs, Modern Healthcare tells us that

A number of insurers, pharmacy benefit managers and technology companies are developing smartphone and computer apps to provide that information for patients and physicians. They provide coverage information before patients reach the pharmacy, inform patients where their prescription can be filled at the lowest cost, and offer alternatives that may be cheaper.The goal is to cut down on cost-driven noncompliance.

Bravo.

Employee Benefit News reports on the strategic importance of employer sponsore health plans acquainting their members with primary care providers.  The FEHBlog believes that encourage annual visits to the PCP is much more important than health risk assessments and third party administered blood tests. Let the doctors do their own work.

The Federal Times reports about three things that federal employees should watch ahead of the FEHB Open Season in November. The first item is the jump in Federal Long Term Care Insurance premiums that the FEHBlog has noted.  Joe Davidson from the Washington Post lets readers rant about the jump today. Tammy Flanagan from Govexec.com provides some sound advice in the FEHBlog’s view. The second item is the once in a blue moon Federal Employee Group Life Insurance Program open season which occurs in September, and the third concerns the FEHB Open Season.

The rest of today’s items also are follow-ups:

• Anti-trust lawsuit update. Business Insurance reports that “Cigna CEO David Cordani told investment analysts {today] that the insurer had stepped back to evaluate its options, but remains “fully engaged” in the [Anthem] merger process and will support Anthem as it takes on the Justice Department’s lawsuit independently.  That publication also advises that the Justice Department is opposing the defendants’ motions to expedite the trials. The FEHBlog thinks that the defendants have the stronger argument on this issue.

• Medicare Hospital Star Ratings. NPR reports that many well known hospitals received low star ratings from Medicare. 

In a statement, Rick Pollack, president of the American Hospital Association, called the new ratings confusing for patients and families. “Health care consumers making critical decisions about their care cannot be expected to rely on a rating system that raises far more questions than answers,” he said. “We are especially troubled that the current ratings scheme unfairly penalizes teaching hospitals and those serving higher numbers of the poor.”

This calls the credibility of the ratings into question, in the FEHBlog’s view. In the FEHBlog’s experience, your best bet is to ask a nurse about hospital quality.

• Zika.   The Washington Post reports that “Florida and federal officials on Friday confirmed the first local spread of the Zika virus through infected mosquitoes in the continental United States.” The Boston Globe’s STAT helpfully offers a daily Zika update. On the bright side, STAT reports that

A group of researchers has identified two dozen Food and Drug Administration-approved drugs that have shown some ability to block Zika from infecting human cells in the lab, according to a paper published Thursday in the journal Cell Host & Microbe. Some of these drugs — which treat infections, cancers, and even depression— also showed potential to prevent infection in certain cells tied to fetal defects in pregnant women. The research is preliminary and does not have immediate implications for people wanting to protect themselves from a Zika infection. Instead, it provides a winnowed list of drugs to study further, said Dr. Mariano Garcia-Blanco, the paper’s senior author.

Federal News Radio reports that “Two Virginia congressmen are demanding answers from the Office of Personnel Management on why the premiums for the Federal Long Term Care Insurance Program are rising by as much as 126 percent.”  In the FEHBlog’s view, the time has come for Congress to start providing a government contribution toward this enrollee pay all product.  Otherwise, people who have paid FLTCIP premiums for years will be forced to reduce or drop their coverage.

The Centers for Medicare and Medicaid Services have been quite busy this week. Earlier this week, as reported in Cardiovascular Business, CMS proposed a Medicare pilot program for bundling payments for cardiac care.  Like the hip and knee replacement bundled payment pilot, participation would be mandatory for those lucky hospitals that CMS selects out of 98 metropolitan areas.  Modern Healthcare reports on how hospitals are reacting to this proposal.  Today, CMS added a star rating system for U.S. hospitals to Hospital Compare.  Modern Healthcare reports that hospitals are not thrilled with this development.

The Boston Globe’s STAT is reporting that payers are not yet latching onto new tools for assessing the value of new prescription drugs.

HHS’s Office for Civil Rights claimed another University scalp this week as a result of alleged HIPAA privacy and security rule violations.  Healthcare IT News reports on a ProPublica survey of public complaints to OCR alleging HIPAA violations, most of which do not lead to scalping.

Reuters had an interesting story about the legal strategy that Aetna and Humana plan to use against the government’s antitrust lawsuit in an effort to block their merger.

The Justice Department lawsuit focused on a county-by-county analysis of where Aetna and Humana have what is deemed too much market share in providing Medicare Advantage for elderly people and in the individual health plans created under President Barack Obama’s healthcare reform law.
Aetna will argue in court that the Justice Department defined the market for Medicare Advantage too narrowly, which has caused it to see competition issues where they do not exist, Chief Executive Officer Mark Bertolini said in an interview. The government has failed to take into account that seniors can not only choose between Medicare Advantage plans sold by private players, but also have the government-run Medicare program as an option.
“Let a judge decide. Is Medicare Advantage competitive with Medicare fee-for-service? If that is indeed the case, then there isn’t any market we need to divest,” Bertolini said. “If we have to divest, can we provide an appropriate remedy? And we have.”

The FEHBlog believes that Mr. Bertolini’s argument finds support in President Obama’s recent American Medicare Association Journal article advocating that “Congress should revisit a public plan [for the ACA marketplaces] to compete alongside insurers in areas of the country where competition is limited. ” As previously noted, the FEHBlog is not a fan of the public option.  The Heritage Foundation expert Bob Moffitt had an article providing in-depth support for this position.

Barrons informs us about challenges facing the prescription benefit management industry.  This is an article worth reading.

Healthcare IT News reports that late last week the FBI arrested three people from Miami-Dade, Florida for a $1 billion scheme to defraud Medicare and Medicaid throught skilled nursing and assisted care facilities. That’s a lot of boxes of ziti as Tony Soprano would say.  Southern Florida with its high elderly popultion always has been a hot bed for health care fraud.

Finally the Washington Post this morning published another one of its feature articles about health care problems plaguing lower income populations in the U.S.  The unfortunate case here concerns a young women who graduated from prescription pain killers to heroin and methadone.  The principal cause of this problem — overprescription of opioids and other pain killers — has been the focus of a massive amount of public attention like this series of articles and a new federal law. Hopefully the problem will dissipate before long.

Aetna and Anthem each released statements saying they intend to fight for their deals. But the Anthem-Cigna tie-up appears to be on its deathbed, with Cigna expressing doubt of an approval. “We do not believe the transaction will close in 2016, and the earliest it could close is 2017, if at all,” Cigna’s statement reads. Cigna disclosed pessimism on the prospects of the deal in its first quarter regulatory filing with the Securities and Exchange Commission. 

BNA has a story that clearly illustrates the convoluted nature of the ACA’s employer shared responsibility mandate.  Business Insurance reports on a further proposed complication to the rules implementing that mandate.

Finally, Fierce Healthcare tells us about an interesting JAMA Internal Medicine study on the impact of generic drugs on the prescription drug market and Drug Channels considers that market in the context of the recent CMS projection.